Skip to main content
Caplight Logo









OneThree Biotech

OneThree Biotech

Private
New York City, New YorkHealthcare & Life Scienceshttps://onethree.bio

Last Round

Seed

Mar 26, 2020

Total Funding Raised

$2.68M

Company Overview

OneThree Biotech is a biotechnology company that provides a biology-driven artificial intelligence platform to optimize pre-clinical drug discovery and development.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, Precision Medicine, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Application

Keywords

drug discoverycomputational biologyAI drug discoveryin silico drug discoveryprecision medicinemulti-omicspredictive analyticstoxicity screeningmechanism of actiontarget identificationgenerative AIbiotech R&DADME predictiontherapeutic candidates

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

OneThree Biotech Comparables

Compare OneThree Biotech with similar companies based on industry and business-model similarity.

OneThree Biotech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
AI Vivo
86%
Aitia
83%
Epigene Labs
81%

OneThree Biotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMar 26, 2020

OneThree Biotech Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 5, 2024

    Grew 100% QoQ from 4 to 8 employees.

  • Sep 28, 2024

    Grew 167% QoQ, from 3 to 8 employees.

OneThree Biotech Filings

Explore SEC and related filing metadata, where available.

OneThree Biotech filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about OneThree Biotech's valuation, stock price, and market status.

Is OneThree Biotech a public or private company?

OneThree Biotech is a private company.

What is the current stock price of OneThree Biotech?

OneThree Biotech is a private company with no public stock price. No recent secondary market data is available.

How much is OneThree Biotech worth (valuation)?

Valuation information for OneThree Biotech is not publicly available.

Can I buy OneThree Biotech stock?

OneThree Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was OneThree Biotech's last funding round?

OneThree Biotech's most recent funding round was Seed on March 26, 2020.

Who are the main investors in OneThree Biotech?

Key investors in OneThree Biotech include Meridian Street Capital, Primary Venture Partners.

Will OneThree Biotech IPO soon?

No public IPO plans have been announced for OneThree Biotech.

How can I track OneThree Biotech secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor OneThree Biotech's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNew York City, New York
Employee Range6
Year Founded2018
Last FundingMar 26, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?